Outsourcing Formulation Services for Biologics...Vadgama P
| Publicado en: | Pharmaceutical Technology Vol. 47; no. 9; pp. 46 - 49 |
|---|---|
| Autor principal: | |
| Formato: | interview pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Sep2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=171851280&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 171851280 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15432521 4FK jtl: Pharmaceutical Technology issn: 15432521 maglogo: N pubinfo: dt: Sep2023 vid: 47 iid: 9 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 171851280 171851280 171851280 171851280 ppf: 46 ppct: 3 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Outsourcing Formulation Services for Biologics...Vadgama P aug: au: Thomas, Felicity sug: subj: Contract Services Utilization Chemistry, Pharmaceutical Biological Products Therapeutics Drug Development Economics COVID-19 Pandemic Chronic Disease Cost Benefit Analysis pubtype: Trade Publication doctype: interview pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|